Search Results - "Nanez, Juan"

The Impact of Community Health Information Exchange Usage on Time to Reutilization of Hospital Services by Sloan-Aagard, Chantel, Glenn, Jeffrey, Nañez, Juan, Crawford, Scott B, Currey, J C, Hartmann, Emily

“…Few studies have determined whether clinician usage of a community health information exchange (HIE) directly improves patient care transitions. We…”
Get full text

The value of community-integrated health information exchanges: three recent examples from El Paso, Texas by Sloan-Aagard, Chantel, Helgesen, Wanda, Nañez, Juan, Law, Jon, Currey, J C, Meils, Jacob, Bishop, Joel, Hartmann, Emily

“…The foundational role of health information exchanges (HIEs) is to facilitate communication between clinical partners in real time. Once this infrastructure…”
Get full text

Effectiveness of BNT162b2 COVID-19 Vaccination in Children and Adolescents by Klein, Nicola P, Demarco, Maria, Fleming-Dutra, Katherine E, Stockwell, Melissa S, Kharbanda, Anupam B, Gaglani, Manjusha, Rao, Suchitra, Lewis, Ned, Irving, Stephanie A, Hartmann, Emily, Natarajan, Karthik, Dalton, Alexandra F, Zerbo, Ousseny, DeSilva, Malini B, Konatham, Deepika, Stenehjem, Edward, Rowley, Elizabeth A K, Ong, Toan C, Grannis, Shaun J, Sloan-Aagard, Chantel, Han, Jungmi, Verani, Jennifer R, Raiyani, Chandni, Dascomb, Kristin, Reese, Sarah E, Barron, Michelle A, Fadel, William F, Naleway, Allison L, Nanez, Juan, Dickerson, Monica, Goddard, Kristin, Murthy, Kempapura, Grisel, Nancy, Weber, Zacharay A, Dixon, Brian E, Patel, Palak, Fireman, Bruce, Arndorfer, Julie, Valvi, Nimish R, Griggs, Eric P, Hallowell, Carly, Embi, Peter J, Ball, Sarah W, Thompson, Mark G, Tenforde, Mark W, Link-Gelles, Ruth

“…We assessed BNT162b2 vaccine effectiveness (VE) against mild to moderate and severe coronavirus disease 2019 (COVID-19) in children and adolescents through the…”
Get full text

Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness by Dalton, Alexandra F, Weber, Zachary A, Allen, Katie S, Stenehjem, Edward, Irving, Stephanie A, Spark, Talia L, Adams, Katherine, Zerbo, Ousseny, Lazariu, Victoria, Dixon, Brian E, Dascomb, Kristin, Hartmann, Emily, Kharbanda, Anupam B, Ong, Toan C, DeSilva, Malini B, Beaton, Maura, Gaglani, Manjusha, Patel, Palak, Naleway, Allison L, Kish, Magdalene N S, Grannis, Shaun J, Grisel, Nancy, Sloan-Aagard, Chantel, Rao, Suchitra, Raiyani, Chandni, Dickerson, Monica, Bassett, Elizabeth, Fadel, William F, Arndorfer, Julie, Nanez, Juan, Barron, Michelle A, Vazquez-Benitez, Gabriela, Liao, I Chia, Griggs, Eric P, Reese, Sarah E, Valvi, Nimish R, Murthy, Kempapura, Rowley, Elizabeth A K, Embi, Peter J, Ball, Sarah, Link-Gelles, Ruth, Tenforde, Mark W

“…Abstract Background Coronavirus disease 2019 (COVID-19) vaccination coverage remains lower in communities with higher social vulnerability. Factors such as…”
Get full text

Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods by Link-Gelles, Ruth, Levy, Matthew E, Natarajan, Karthik, Reese, Sarah E, Naleway, Allison L, Grannis, Shaun J, Klein, Nicola P, DeSilva, Malini B, Ong, Toan C, Gaglani, Manjusha, Hartmann, Emily, Dickerson, Monica, Stenehjem, Edward, Kharbanda, Anupam B, Han, Jungmi, Spark, Talia L, Irving, Stephanie A, Dixon, Brian E, Zerbo, Ousseny, McEvoy, Charlene E, Rao, Suchitra, Raiyani, Chandni, Sloan-Aagard, Chantel, Patel, Palak, Dascomb, Kristin, Uhlemann, Anne-Catrin, Dunne, Margaret M, Fadel, William F, Lewis, Ned, Barron, Michelle A, Murthy, Kempapura, Nanez, Juan, Griggs, Eric P, Grisel, Nancy, Annavajhala, Medini K, Akinseye, Akintunde, Valvi, Nimish R, Goddard, Kristin, Mamawala, Mufaddal, Arndorfer, Julie, Yang, Duck-Hye, Embí, Peter J, Fireman, Bruce, Ball, Sarah W, Tenforde, Mark W

“…Recent SARS-CoV-2 Omicron variant sublineages, including BA.4 and BA.5, may be associated with greater immune evasion and less protection against COVID-19…”
Get full text

Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022 by Britton, Amadea, Embi, Peter J, Levy, Matthew E, Gaglani, Manjusha, DeSilva, Malini B, Dixon, Brian E, Dascomb, Kristin, Patel, Palak, Schrader, Kristin E, Klein, Nicola P, Ong, Toan C, Natarajan, Karthik, Hartmann, Emily, Kharbanda, Anupam B, Irving, Stephanie A, Dickerson, Monica, Dunne, Margaret M, Raiyani, Chandni, Grannis, Shaun J, Stenehjem, Edward, Zerbo, Ousseny, Rao, Suchitra, Han, Jungmi, Sloan-Aagard, Chantel, Griggs, Eric P, Weber, Zachary A, Murthy, Kempapura, Fadel, William F, Grisel, Nancy, McEvoy, Charlene, Lewis, Ned, Barron, Michelle A, Nanez, Juan, Reese, Sarah E, Mamawala, Mufaddal, Valvi, Nimish R, Arndorfer, Julie, Goddard, Kristin, Yang, Duck-Hye, Fireman, Bruce, Ball, Sarah W, Link-Gelles, Ruth, Naleway, Allison L, Tenforde, Mark W

“…Persons with moderate-to-severe immunocompromising conditions might have reduced protection after COVID-19 vaccination, compared with persons without…”
Get full text

Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021–February 2022, VISION Network: a retrospective cohort study by Adams, Katherine, Riddles, John J., Rowley, Elizabeth A.K., Grannis, Shaun J., Gaglani, Manjusha, Fireman, Bruce, Hartmann, Emily, Naleway, Allison L., Stenehjem, Edward, Hughes, Alexandria, Dalton, Alexandra F., Natarajan, Karthik, Dascomb, Kristin, Raiyani, Chandni, Irving, Stephanie A., Sloan-Aagard, Chantel, Kharbanda, Anupam B., DeSilva, Malini B., Dixon, Brian E., Ong, Toan C., Keller, Jean, Dickerson, Monica, Grisel, Nancy, Murthy, Kempapura, Nanez, Juan, Fadel, William F., Ball, Sarah W., Patel, Palak, Arndorfer, Julie, Mamawala, Mufaddal, Valvi, Nimish R., Dunne, Margaret M., Griggs, Eric P., Embi, Peter J., Thompson, Mark G., Link-Gelles, Ruth, Tenforde, Mark W.

“…Understanding the usefulness of additional COVID-19 vaccine doses—particularly given varying disease incidence—is needed to support public health policy. We…”
Get full text

Number needed to vaccinate with a COVID-19 booster to prevent a COVID-19-associated hospitalization during SARS-CoV-2 Omicron BA.1 variant predominance, December 2021–February 2022, VISION Network: a retrospective cohort studyResearch in context by Katherine Adams, John J. Riddles, Elizabeth A.K. Rowley, Shaun J. Grannis, Manjusha Gaglani, Bruce Fireman, Emily Hartmann, Allison L. Naleway, Edward Stenehjem, Alexandria Hughes, Alexandra F. Dalton, Karthik Natarajan, Kristin Dascomb, Chandni Raiyani, Stephanie A. Irving, Chantel Sloan-Aagard, Anupam B. Kharbanda, Malini B. DeSilva, Brian E. Dixon, Toan C. Ong, Jean Keller, Monica Dickerson, Nancy Grisel, Kempapura Murthy, Juan Nanez, William F. Fadel, Sarah W. Ball, Palak Patel, Julie Arndorfer, Mufaddal Mamawala, Nimish R. Valvi, Margaret M. Dunne, Eric P. Griggs, Peter J. Embi, Mark G. Thompson, Ruth Link-Gelles, Mark W. Tenforde

“…Background: Understanding the usefulness of additional COVID-19 vaccine doses—particularly given varying disease incidence—is needed to support public health…”
Get full text